Readers respond

From the Inbox: the Medical Research Council and the Human Tissue Bill

Written byThe Editor
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

To the Editor:

I read with interest your article on the new draft bill for human tissue in the UK and found the Medical Research Council's comments very ironic. During the mid 1990s, I was involved in research into a scandal involving the use of gonadotropin extracted from human pituitary gland obtained from cadavers. The glands had been extracted without consent, and because they were taken by mortuary technicians instead of registered medical practitioners in breach of the current and totally inadequate Human Tissues Act of 1961, a good number of those treated with the hGH serum contracted Creutzfeldt-Jakob disease. At a subsequent civil trial, the Medical Research Council was found culpable in this tragedy. I am now interested to see that they think that an effective piece of legislation to replace the ineffective one threatens research into the very disease they negligently inflicted many patients with.

Barry Turner (bturner@lincoln.ac.uk)

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery